Stock Track | Rhythm Pharmaceuticals Soars 9.84% in Pre-market on Better-Than-Expected Q1 Results

Stock Track
05/05

Rhythm Pharmaceuticals Inc. (RYTM) saw its stock price surge 9.84% during the pre-market session on Tuesday.

The significant move higher follows the company's release of its first quarter 2026 financial results, which exceeded analyst expectations. Rhythm Pharmaceuticals reported an EPS of $(0.83), beating the consensus estimate of $(0.84), while sales came in at $60.112 million, surpassing the $55.776 million forecast.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10